The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic and molecular biomarker characterization of KRAS mutant non-small cell lung carcinoma (NSCLC) tumors.
Li Liu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Yuan Liu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Ademi Santiago-Walker
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Hong Shi
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Vivian Zhang
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Ashley Hughes
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Carmen P. Arenas-Elliott
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Lori Roadcap
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Anne-Marie Martin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Tona M. Gilmer
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline